Who owns the EMINENCE CLINICAL RESEARCH trademark?

The EMINENCE CLINICAL RESEARCH trademark is owned by Eminence Clinical Research, Inc..

What class is the EMINENCE CLINICAL RESEARCH trademark registered in?

The EMINENCE CLINICAL RESEARCH trademark is registered in Class 035 (Advertising, business management & retail services), Class 041 (Education & entertainment services).

What is the serial number for EMINENCE CLINICAL RESEARCH?

The USPTO serial number for EMINENCE CLINICAL RESEARCH is 77832074.

What is the registration number for EMINENCE CLINICAL RESEARCH?

EMINENCE CLINICAL RESEARCH is registered under USPTO registration number 3905348.

EMI

USPTO Trademark Record

REGISTERED

EMINENCE CLINICAL RESEARCH

SN 77832074·Reg 3905348·Filed Sep 22, 2009

Owner Eminence Clinical Research, Inc.

Advertising; business management, organization and administration; office functions.; Education; providing of training; entertainment; sporting and cultural activities.

EMINENCE CLINICAL RESEARCH (Serial No. 77832074), Registration No. 3905348, is a registered US trademark filed on Sep 22, 2009 by Eminence Clinical Research, Inc.. This trademark covers Class 035 (Advertising, business management & retail services), Class 041 (Education & entertainment services).

Section 8/9 declaration window: January 13, 2031

Mark Intelligence

EMINENCE CLINICAL RESEARCH (Reg. #3905348) is a registered US trademark that has been protecting its owner, Eminence Clinical Research, Inc., since 2009. The mark covers Class 035 (Advertising, business management & retail services) and Class 041 (Education & entertainment services) respectively. Goods and services include Advertising; business management, organization and administration; office functions.; Education; providing of training; .... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 22, 2009

SERIAL

77832074

REG#

3905348

REGISTERED

Jan 11, 2011

Owner

Applicant

Eminence Clinical Research, Inc.

Entity

Corporation

State

Address

13521 Northgate Drive, Suite 150, Colorado Springs, CO, 80921

Country

Attorney

Law firm

Eminence Clinical Research, Inc.

Address

13521 Northgate Drive, Suite 150, Colorado Springs, CO 80921, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 22, 2009

Serial Number77832074

Registration No.3905348

Registration DateJan 11, 2011

Status DateApr 09, 2021

Published for OppositionFeb 16, 2010

Next RenewalJanuary 13, 2031

Mark TypeDesign with words

Status DescriptionLive and registered, renewed

Filing Signals

FILED

2009

YEARS AGO

17y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

First use anywhere: Oct 22, 2009

First use in commerce: May 19, 2010

Advertising; business management, organization and administration; office functions.

Class 041Education & entertainment services

US codes: 100, 101, 107

First use anywhere: Oct 22, 2009

First use in commerce: May 19, 2010

Education; providing of training; entertainment; sporting and cultural activities.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

42 events

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Oct 24, 2022

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

WITHDRAWAL OF ATTORNEY GRANTED

Oct 24, 2022

WITHDRAWAL OF ATTORNEY GRANTED

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Apr 09, 2021

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Apr 09, 2021

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Apr 09, 2021

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 08, 2021

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

Apr 08, 2021

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Apr 08, 2021

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

TEAS SECTION 8 & 9 RECEIVED

Dec 23, 2020

TEAS SECTION 8 & 9 RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jan 11, 2020

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Dec 15, 2019

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Dec 15, 2019

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 13, 2017

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Mar 13, 2017

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Mar 13, 2017

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Jan 10, 2017

TEAS SECTION 8 & 15 RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jan 11, 2011

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 07, 2010

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ASSIGNED TO LIE

Dec 06, 2010

ASSIGNED TO LIE

LAW OFFICE REGISTRATION REVIEW COMPLETED

Dec 06, 2010

LAW OFFICE REGISTRATION REVIEW COMPLETED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Nov 12, 2010

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Nov 08, 2010

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 08, 2010

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Oct 25, 2010

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Oct 25, 2010

USE AMENDMENT FILED

NOA MAILED - SOU REQUIRED FROM APPLICANT

May 11, 2010

NOA MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 16, 2010

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 16, 2010

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

ASSIGNED TO LIE

Jan 12, 2010

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jan 12, 2010

LAW OFFICE PUBLICATION REVIEW COMPLETED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 22, 2009

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 22, 2009

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 22, 2009

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 22, 2009

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

Dec 19, 2009

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 19, 2009

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 19, 2009

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 18, 2009

ASSIGNED TO EXAMINER

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 19, 2009

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NOTICE OF DESIGN SEARCH CODE MAILED

Sep 26, 2009

NOTICE OF DESIGN SEARCH CODE MAILED

NEW APPLICATION ENTERED

Sep 25, 2009

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 25, 2009

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

EMINENCE CLINICAL RESEARCH

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Eminence Clinical Research, Inc.

Other Marks in Class 035 — Advertising, business management & retail services

Resources

Company